The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Artificial Vital Organs and Medical Bionics Market Research Report 2024

Global Artificial Vital Organs and Medical Bionics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1600458

No of Pages : 108

Ask Your Query
Synopsis
The artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology. The increasing mortality rate of patients awaiting organ transplant has intensified the demand for artificial organs. The artificial vital organs and medical bionics market is undergoing impressive growth across the globe due to increase in the gap between patients awaiting organ transplant and the availability of donor organs.
The global Artificial Vital Organs and Medical Bionics market was valued at US$ 44420 million in 2023 and is anticipated to reach US$ 74740 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Artificial Vital Organs and Medical Bionics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Vital Organs and Medical Bionics.
Report Scope
The Artificial Vital Organs and Medical Bionics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Vital Organs and Medical Bionics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Vital Organs and Medical Bionics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter
Cyberonics, Inc.
Edwards
Ekso Bionics
Roche
Fresenius
Baxter International
Iwalk
Jarvik Heart
Medtronic
Micromed Cardiovascular
Nikkiso
Ossur Hf
Ottobock
Second Sight Medical Products, Inc.
Syncardia Systems, Inc.
Thoratec Corporation
Touch Bionics, Inc.
Vital Therapies, Inc.
WorldHeart Corporation
Segment by Type
Artificial Vital Organs
Bionics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Vital Organs and Medical Bionics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Artificial Vital Organs
1.2.3 Bionics
1.3 Market by Application
1.3.1 Global Artificial Vital Organs and Medical Bionics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Vital Organs and Medical Bionics Market Perspective (2019-2030)
2.2 Artificial Vital Organs and Medical Bionics Growth Trends by Region
2.2.1 Global Artificial Vital Organs and Medical Bionics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Vital Organs and Medical Bionics Historic Market Size by Region (2019-2024)
2.2.3 Artificial Vital Organs and Medical Bionics Forecasted Market Size by Region (2025-2030)
2.3 Artificial Vital Organs and Medical Bionics Market Dynamics
2.3.1 Artificial Vital Organs and Medical Bionics Industry Trends
2.3.2 Artificial Vital Organs and Medical Bionics Market Drivers
2.3.3 Artificial Vital Organs and Medical Bionics Market Challenges
2.3.4 Artificial Vital Organs and Medical Bionics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Vital Organs and Medical Bionics Players by Revenue
3.1.1 Global Top Artificial Vital Organs and Medical Bionics Players by Revenue (2019-2024)
3.1.2 Global Artificial Vital Organs and Medical Bionics Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Vital Organs and Medical Bionics Revenue
3.4 Global Artificial Vital Organs and Medical Bionics Market Concentration Ratio
3.4.1 Global Artificial Vital Organs and Medical Bionics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Vital Organs and Medical Bionics Revenue in 2023
3.5 Artificial Vital Organs and Medical Bionics Key Players Head office and Area Served
3.6 Key Players Artificial Vital Organs and Medical Bionics Product Solution and Service
3.7 Date of Enter into Artificial Vital Organs and Medical Bionics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Vital Organs and Medical Bionics Breakdown Data by Type
4.1 Global Artificial Vital Organs and Medical Bionics Historic Market Size by Type (2019-2024)
4.2 Global Artificial Vital Organs and Medical Bionics Forecasted Market Size by Type (2025-2030)
5 Artificial Vital Organs and Medical Bionics Breakdown Data by Application
5.1 Global Artificial Vital Organs and Medical Bionics Historic Market Size by Application (2019-2024)
5.2 Global Artificial Vital Organs and Medical Bionics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Vital Organs and Medical Bionics Market Size (2019-2030)
6.2 North America Artificial Vital Organs and Medical Bionics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Vital Organs and Medical Bionics Market Size by Country (2019-2024)
6.4 North America Artificial Vital Organs and Medical Bionics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Vital Organs and Medical Bionics Market Size (2019-2030)
7.2 Europe Artificial Vital Organs and Medical Bionics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Vital Organs and Medical Bionics Market Size by Country (2019-2024)
7.4 Europe Artificial Vital Organs and Medical Bionics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Vital Organs and Medical Bionics Market Size (2019-2030)
8.2 Asia-Pacific Artificial Vital Organs and Medical Bionics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Vital Organs and Medical Bionics Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Vital Organs and Medical Bionics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Vital Organs and Medical Bionics Market Size (2019-2030)
9.2 Latin America Artificial Vital Organs and Medical Bionics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Vital Organs and Medical Bionics Market Size by Country (2019-2024)
9.4 Latin America Artificial Vital Organs and Medical Bionics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Vital Organs and Medical Bionics Market Size (2019-2030)
10.2 Middle East & Africa Artificial Vital Organs and Medical Bionics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Vital Organs and Medical Bionics Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Vital Organs and Medical Bionics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Artificial Vital Organs and Medical Bionics Introduction
11.1.4 Abbott Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Abiomed, Inc.
11.2.1 Abiomed, Inc. Company Detail
11.2.2 Abiomed, Inc. Business Overview
11.2.3 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Introduction
11.2.4 Abiomed, Inc. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.2.5 Abiomed, Inc. Recent Development
11.3 Asahi Kasei Medical Co., Ltd.
11.3.1 Asahi Kasei Medical Co., Ltd. Company Detail
11.3.2 Asahi Kasei Medical Co., Ltd. Business Overview
11.3.3 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Introduction
11.3.4 Asahi Kasei Medical Co., Ltd. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.3.5 Asahi Kasei Medical Co., Ltd. Recent Development
11.4 Baxter
11.4.1 Baxter Company Detail
11.4.2 Baxter Business Overview
11.4.3 Baxter Artificial Vital Organs and Medical Bionics Introduction
11.4.4 Baxter Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.4.5 Baxter Recent Development
11.5 Cyberonics, Inc.
11.5.1 Cyberonics, Inc. Company Detail
11.5.2 Cyberonics, Inc. Business Overview
11.5.3 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Introduction
11.5.4 Cyberonics, Inc. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.5.5 Cyberonics, Inc. Recent Development
11.6 Edwards
11.6.1 Edwards Company Detail
11.6.2 Edwards Business Overview
11.6.3 Edwards Artificial Vital Organs and Medical Bionics Introduction
11.6.4 Edwards Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.6.5 Edwards Recent Development
11.7 Ekso Bionics
11.7.1 Ekso Bionics Company Detail
11.7.2 Ekso Bionics Business Overview
11.7.3 Ekso Bionics Artificial Vital Organs and Medical Bionics Introduction
11.7.4 Ekso Bionics Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.7.5 Ekso Bionics Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Artificial Vital Organs and Medical Bionics Introduction
11.8.4 Roche Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.8.5 Roche Recent Development
11.9 Fresenius
11.9.1 Fresenius Company Detail
11.9.2 Fresenius Business Overview
11.9.3 Fresenius Artificial Vital Organs and Medical Bionics Introduction
11.9.4 Fresenius Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.9.5 Fresenius Recent Development
11.10 Baxter International
11.10.1 Baxter International Company Detail
11.10.2 Baxter International Business Overview
11.10.3 Baxter International Artificial Vital Organs and Medical Bionics Introduction
11.10.4 Baxter International Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.10.5 Baxter International Recent Development
11.11 Iwalk
11.11.1 Iwalk Company Detail
11.11.2 Iwalk Business Overview
11.11.3 Iwalk Artificial Vital Organs and Medical Bionics Introduction
11.11.4 Iwalk Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.11.5 Iwalk Recent Development
11.12 Jarvik Heart
11.12.1 Jarvik Heart Company Detail
11.12.2 Jarvik Heart Business Overview
11.12.3 Jarvik Heart Artificial Vital Organs and Medical Bionics Introduction
11.12.4 Jarvik Heart Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.12.5 Jarvik Heart Recent Development
11.13 Medtronic
11.13.1 Medtronic Company Detail
11.13.2 Medtronic Business Overview
11.13.3 Medtronic Artificial Vital Organs and Medical Bionics Introduction
11.13.4 Medtronic Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.13.5 Medtronic Recent Development
11.14 Micromed Cardiovascular
11.14.1 Micromed Cardiovascular Company Detail
11.14.2 Micromed Cardiovascular Business Overview
11.14.3 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Introduction
11.14.4 Micromed Cardiovascular Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.14.5 Micromed Cardiovascular Recent Development
11.15 Nikkiso
11.15.1 Nikkiso Company Detail
11.15.2 Nikkiso Business Overview
11.15.3 Nikkiso Artificial Vital Organs and Medical Bionics Introduction
11.15.4 Nikkiso Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.15.5 Nikkiso Recent Development
11.16 Ossur Hf
11.16.1 Ossur Hf Company Detail
11.16.2 Ossur Hf Business Overview
11.16.3 Ossur Hf Artificial Vital Organs and Medical Bionics Introduction
11.16.4 Ossur Hf Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.16.5 Ossur Hf Recent Development
11.17 Ottobock
11.17.1 Ottobock Company Detail
11.17.2 Ottobock Business Overview
11.17.3 Ottobock Artificial Vital Organs and Medical Bionics Introduction
11.17.4 Ottobock Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.17.5 Ottobock Recent Development
11.18 Second Sight Medical Products, Inc.
11.18.1 Second Sight Medical Products, Inc. Company Detail
11.18.2 Second Sight Medical Products, Inc. Business Overview
11.18.3 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Introduction
11.18.4 Second Sight Medical Products, Inc. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.18.5 Second Sight Medical Products, Inc. Recent Development
11.19 Syncardia Systems, Inc.
11.19.1 Syncardia Systems, Inc. Company Detail
11.19.2 Syncardia Systems, Inc. Business Overview
11.19.3 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Introduction
11.19.4 Syncardia Systems, Inc. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.19.5 Syncardia Systems, Inc. Recent Development
11.20 Thoratec Corporation
11.20.1 Thoratec Corporation Company Detail
11.20.2 Thoratec Corporation Business Overview
11.20.3 Thoratec Corporation Artificial Vital Organs and Medical Bionics Introduction
11.20.4 Thoratec Corporation Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.20.5 Thoratec Corporation Recent Development
11.21 Touch Bionics, Inc.
11.21.1 Touch Bionics, Inc. Company Detail
11.21.2 Touch Bionics, Inc. Business Overview
11.21.3 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Introduction
11.21.4 Touch Bionics, Inc. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.21.5 Touch Bionics, Inc. Recent Development
11.22 Vital Therapies, Inc.
11.22.1 Vital Therapies, Inc. Company Detail
11.22.2 Vital Therapies, Inc. Business Overview
11.22.3 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Introduction
11.22.4 Vital Therapies, Inc. Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.22.5 Vital Therapies, Inc. Recent Development
11.23 WorldHeart Corporation
11.23.1 WorldHeart Corporation Company Detail
11.23.2 WorldHeart Corporation Business Overview
11.23.3 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Introduction
11.23.4 WorldHeart Corporation Revenue in Artificial Vital Organs and Medical Bionics Business (2019-2024)
11.23.5 WorldHeart Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock